Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Conditions
Diabetic Kidney Disease (DKD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Apogee Clinical Research, LLC, Huntsville, Alabama, United States
Applied Research Center of Arkansas, Little Rock, Arkansas, United States
AME Clinical Research, Huntington Beach, California, United States
Amicis Research Center, Northridge, California, United States
FOMAT - Vista del Mar Medical Group, Oxnard, California, United States
Central Coast Nephrology, Salinas, California, United States
North America Research Institute, San Dimas, California, United States
Amicis Research Center, Santa Clarita, California, United States
Valiance Clinical Research, Tarzana, California, United States
Amicis Research Center, Valencia, California, United States
National Institute of Clinical Research, Inc., Victorville, California, United States
Yale University, New Haven, Connecticut, United States
D&H Doral Research Center, Doral, Florida, United States
AGA Clinical Trials, Hialeah, Florida, United States
Convenient Medical Center, Hialeah, Florida, United States
Elixia Hollywood, Hollywood, Florida, United States
D&H Pompano Research Center, Margate, Florida, United States
LCC Medical Research Institute, Miami, Florida, United States
D&H National Research Centers, Inc, Miami, Florida, United States
Regenerate Primary Medical Research, LLC, Miami, Florida, United States
Ocean Blue Medical Research Center - Internal Medicine, Miami Springs, Florida, United States
Innovia Research Center, Miramar, Florida, United States
Central Florida Kidney Specialists Oakwater, Orlando, Florida, United States
Bolanos Clinical Research, Pembroke Pines, Florida, United States
Progressive Medical Research, Port Orange, Florida, United States
CDC Research Institute, Port Saint Lucie, Florida, United States
D&H Tamarac Research Center, Tamarac, Florida, United States
Metabolic Research Institute, West Palm Beach, Florida, United States
Privia Medical Group of Georgia, LLC, Savannah, Georgia, United States
Research by Design, LLC - Internal Medicine, Chicago, Illinois, United States
IMA Clinical Research, Monroe, Louisiana, United States
Elixia Michigan Kidney Consultants, Pontiac, Michigan, United States
Elixia MNA, City of Saint Peters, Missouri, United States
Clinical Research Consultants, LLC, Kansas City, Missouri, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
DaVita Clinical Research, Las Vegas, Nevada, United States
Velocity Clinical Research, Binghamton, New York, United States
CHEAR Center LLC, The Bronx, New York, United States
Eastern Nephrology Associates - Greenville West, Greenville, North Carolina, United States
Eastern Nephrology Associates - New Bern, New Bern, North Carolina, United States
Brookview Hills Research Associates, LLC, Winston-Salem, North Carolina, United States
Northeast Clinical Research Center, Bethlehem, Pennsylvania, United States
Suburban Research Associates, West Chester, Pennsylvania, United States
Southeast Renal Research Institute, Chattanooga, Tennessee, United States
Arlington Nephrology, PLLC., Arlington, Texas, United States
M3 Wake Research Dallas - Internal Medicine, Dallas, Texas, United States
Revival Research Institute, LLC, Dallas, Texas, United States
Epic Medical Research LLC, DeSoto, Texas, United States
El Paso Kidney Specialists-Davita Clinical Research, El Paso, Texas, United States
Juno Research, LLC, Houston, Texas, United States
Prolato Research LLC, Houston, Texas, United States
Clinical Trial Network, LLC, Houston, Texas, United States
Gulf Coast Clinical Research, Katy, Texas, United States
R & H Clinical Research, Inc., Katy, Texas, United States
Sunbeam Clinical Research, McKinney, Texas, United States
Clinical Advancement Center, San Antonio, Texas, United States
University of Texas Health - San Antonio, San Antonio, Texas, United States
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals